Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear Members, The early bird registration deadline for CBS 2023 in Halifax has been extended to April 21st, 2023 To register, click here...

Dear Members, The abstract submission deadline for CBS 2023 in Halifax has been extended to March 17th, 2023 Please click here to learn more...

The Exploration of Biomat-X EBMX invites you to submit your next original contribution to the inaugural edition of this journal to help the journal positioning itself among the major players in the field...

Dear Members, Reistration for CBS 2023 at Dalhousie University in Halifax, NS is officially open You can register here...

Type 1 diabetes is an autoimmune disorder which causes the destruction of insulin-producing pancreatic beta cells...

Cell therapy is increasingly used to treat various diseases such myocardial infarction. This therapeutic approach is limited however by the poor retention and diminished survival of transplanted cells in the ischemic, inflammatory and oxidative infarct microenvironment...

The development of new biomaterials has opened up new avenues of drug delivery, bio-monitoring and other implantable medical devices 1 ...

Over 800 000 Canadians suffer from peripheral arterial disease PAD 1, a condition which leads to critical limb ischemia and high risks of amputation and mortality...

Protein-, lipid- and cell-based products constitute a significant portion of current and upcoming therapeutics and have become a prime focus of the pharmaceutical and biotechnology industries...